Drug Shortage Report for BRIVLERA
| Report ID | 229811 |
| Drug Identification Number | 02452987 |
| Brand name | BRIVLERA |
| Common or Proper name | Brivlera OS 300ml Bottle |
| Company Name | UCB CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | BRIVARACETAM |
| Strength(s) | 10MG |
| Dosage form(s) | SOLUTION |
| Route of administration | ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 300ml Bottle |
| ATC code | N03AX |
| ATC description | ANTIEPILEPTICS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2024-06-10 |
| Actual start date | 2024-06-06 |
| Estimated end date | 2024-06-17 |
| Actual end date | 2024-06-12 |
| Shortage status | Resolved |
| Updated date | 2024-06-13 |
| Company comments | Inventory is in Canada Warehouse. AMR product, so awaiting PIT results from lab. Expected on 14/6/24, with release expected shortly after. Update 13/6/24: Release complete and backorders to wholesalers filled. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2201 BRISTOL CIRCLE OAKVILLE, ONTARIO CANADA L6H 0J8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2024-06-13 | French | Compare |
| v4 | 2024-06-13 | English | Compare |
| v3 | 2024-06-07 | English | Compare |
| v2 | 2024-06-06 | French | Compare |
| v1 | 2024-06-06 | English | Compare |
Showing 1 to 5 of 5